Back to Dashboard
DXCM · Healthcare

Dexcom Inc

USA Healthcare Filing: 2026-06-30
39/100
Smart-money confidence
Below average interest

1 member of Congress bought

Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →

9
hedge funds
hold it · 4 added, 4 trimmed
2
in Congress
traded it in the past year · 1 bought, 1 sold
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works Consensus buy — 2 of 3 sources positive →
Market cap
$29.6B
Industry
Medical Devices
Sector
Healthcare
Exchange
NasdaqGS
About DEXCOM INC

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and…

Who's behind the signal
Every informed buyer we can see on DXCM, across all three feeds.
Hedge funds · 9
Renaissance Technologies Increased +3%
AQR Capital Management Increased +49%
Point72 (Steve Cohen) Increased +10%
Citadel Advisors Decreased −42%
+3 more in the full breakdown below ↓
Congress · 9
Tina Smith sold
John Boozman bought
Kevin Hern sold
+1 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 22 on record
Disclosures from 2020-03-17 to 2026-05-07
Trade date Member Chamber Action Amount
2026-05-07 Tina Smith · D-MN Senate Sold $100,001 - $250,000
2026-04-29 Tina Smith · D-MN Senate Sold $100,001 - $250,000
2026-01-26 John Boozman · R-AR Senate Bought $1,001 - $15,000
2025-05-15 Robert P. Bresnahan, Jr. · R-PA House Bought $1,001 - $15,000
2025-05-12 Jefferson Shreve · R-IN House Sold $15,001 - $50,000
2025-05-08 Jefferson Shreve · R-IN House Bought $15,001 - $50,000
2025-04-08 Robert P. Bresnahan, Jr. · R-PA House Sold $1,001 - $15,000
2025-04-07 Jefferson Shreve · R-IN House Sold $15,001 - $50,000
2025-02-25 Robert P. Bresnahan, Jr. · R-PA House Bought $1,001 - $15,000
2024-12-31 Kevin Hern · R-OK House Sold $50,001 - $100,000
Show the other 12
Trade date Member Chamber Action Amount
2023-09-12 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2023-08-21 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2022-09-28 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2021-07-01 Kevin Hern · R-OK House Bought $100,001 - $250,000
2021-02-16 Peter Meijer · R-MI House Sold $1,001 - $15,000
2020-12-24 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2020-12-22 Gilbert Ray Cisneros, Jr. · D-CA House Sold $1,001 - $15,000
2020-10-02 Susie Lee · D-NV House Sold $1,001 - $15,000
2020-09-16 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2020-08-13 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2020-05-11 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2020-03-17 Tina Smith · D-MN Senate Sold $250,001 - $500,000
Not a model pick — but on our radar. DEXCOM INC isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
0
New positions
4
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset Pinch to zoom · drag sideways to move through time
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to DEXCOM INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell DEXCOM INC or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime · Privacy